Flavonoids as Strong Inhibitors of MAPK3: A Computational Drug Discovery Approach

BACKGROUND: Mitogen-activated protein kinase 3 (MAPK3) mediates the onset, progression, metastasis, drug resistance, and poor prognosis in various malignancies, including glioma, liver, ovarian, thyroid, lung, breast, gastric, and oral cancers. Negative regulation of MAPK3 expression using miRNAs ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Taherkhani, Amir, Khodadadi, Parita, Samie, Lida, Azadian, Zahra, Bayat, Zeynab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121358/
https://www.ncbi.nlm.nih.gov/pubmed/37090055
http://dx.doi.org/10.1155/2023/8899240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121358/
https://www.ncbi.nlm.nih.gov/pubmed/37090055
http://dx.doi.org/10.1155/2023/8899240

Ejemplares similares